At the JavaOne conference today, Oracle made a series of announcements related to a new Java Verified Portfolio (JVP) and new JDK Enhancement Proposals (JEPs).
Gilead to pay $115 per share, 79% premium for Arcellx Anito-cel under FDA review for multiple myeloma treatment Deal highlights Gilead's oncology growth strategy, CEO O'Day says Feb 23 (Reuters) - ...
Linus Torvalds kicked off the development of Linux Kernel 7.0 on Sunday. Two weeks after the release of the last kernel 6.19, he closed the so-called merge window and released the first release ...
Apple's iOS 26.4 beta adds AI-generated Apple Music playlists, early testing for encrypted RCS messaging and a new setting to tone down brighter visual effects. With more than a decade of experience, ...
The worlds of professional sports and entrepreneurship are colliding this summer in Park City, Utah, where elite NFL athletes will meet with proven operators and vetted founders for three days of deal ...
Drug development is a costly, time-intensive and high-risk endeavour, with only two to three approvals for novel therapeutics in new drug classes per year eventually making it to market. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results